Item 9 Labs Balans Gezondheid
Financiële gezondheid criteriumcontroles 1/6
Item 9 Labs has a total shareholder equity of $52.6M and total debt of $33.9M, which brings its debt-to-equity ratio to 64.4%. Its total assets and total liabilities are $112.0M and $59.4M respectively.
Belangrijke informatie
64.4%
Verhouding schuld/eigen vermogen
US$33.90m
Schuld
| Rente dekkingsratio | n/a |
| Contant | US$183.43k |
| Aandelen | US$52.64m |
| Totaal verplichtingen | US$59.37m |
| Totaal activa | US$112.02m |
Recente financiële gezondheidsupdates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: INLB's short term assets ($3.3M) do not cover its short term liabilities ($58.8M).
Langlopende schulden: INLB's short term assets ($3.3M) exceed its long term liabilities ($558.2K).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: INLB's net debt to equity ratio (64.1%) is considered high.
Schuld verminderen: INLB's debt to equity ratio has increased from 51.9% to 64.4% over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: Insufficient data to determine if INLB has enough cash runway based on its current free cash flow.
Voorspelling contante baan: Insufficient data to determine if INLB has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.